Injection could permanently lower cholesterol by changing DNA
New Scientist - 06-Feb-2017People born with natural mutations that disable a specific gene have a lower risk of heart diseas...
Join the club for FREE to access the whole archive and other member benefits.
Life Sciences and BioPharma Professional.
Previously, he was the Chief Technology Officer for GE Healthcare Life Sciences, overseeing R&D investment, research programmes and business growth strategy. Prior to this he held senior leadership positions at Novartis, Astra Zeneca and Bayer. He also holds a position as a Visiting Scientist/Guest Professor at the ETHZ, the Swiss Federal Institute of Technology at Zurich/Switzerland.
Visit website: https://www.synconaltd.com/about-us/our-people/
See also: AstraZeneca - Pharmaceutical and biopharmaceutical company that develops innovative drugs
Details last updated 23-Jul-2020
People born with natural mutations that disable a specific gene have a lower risk of heart diseas...